Argon AI has introduced it secured $5.5 million in seed funding.
Crosslink Capital and Wireframe Ventures co-led the spherical, with participation from Y Combinator, Pioneer Fund and different traders.
WHAT IT DOES
Argon AI presents a platform aimed toward serving to life sciences firms automate data-intensive workflows. Its AI assistants assist with repetitive, guide and rote duties throughout scientific and industrial work.
The AI-enabled platform additionally unifies numerous codecs of business information, together with structured tables, PDFs, slide decks and pictures, throughout totally different information sources equivalent to medical literature, firm info and convention proceedings.
The corporate will use the funds for product enhancements, crew growth and buyer growth.
“Each industrial or scientific technique resolution is constructed on high of fragmented, outdated or hard-to-access info,” Samy Danesh, CEO and cofounder of Argon AI, stated in a press release.
“We’re constructing Argon to make information as accessible and actionable as your inbox and to free life sciences groups to give attention to bringing new remedies to sufferers.”
MARKET SNAPSHOT
Different firms within the information workflow area embody Plenful, a workflow-automation platform for pharmacy and healthcare operations, which in 2024 secured $17 million in Sequence A funding lower than a yr after launching with $9 million in funding.
Plenful presents pharmacy technicians a no-code, AI-enabled automation software for guide and administrative workflows, together with assist with doc information entry for pharmacy income cycle, referral orders, auditing and financial savings identification.
The corporate used the funds to scale its advertising, gross sales and product growth efforts.
That very same yr, SamaCare, a workflow platform for suppliers providing specialty treatment, introduced it secured $17 million in an oversubscribed Sequence B funding spherical.
The corporate presents a cloud-based workflow automation platform to help suppliers in acquiring prior authorization for specialty drug drugs, verifying enrollment and checking advantages.
It additionally works with pharmaceutical firms to offer information analytics to assist enhance entry to their therapies.
The corporate used the funds to increase its Script-to-Remedy Working System, which can leverage AI for administrative duties, create a post-prescription workflow, accumulate information insights and improve collaboration between suppliers’ workplaces.
